(Q38009295)

English

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

scientific article published on 09 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neuromyelitis optica

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

14

object named as

Angela Vincent

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Jacqueline Palace

17

object named as

Jacqueline Palace

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

author name string

Joanna Kitley

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

M Isabel Leite

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Ichiro Nakashima

3

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Patrick Waters

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Benjamin McNeillis

5

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Rachel Brown

6

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Yoshiki Takai

7

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Toshiyuki Takahashi

8

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Tatsuro Misu

9

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Liene Elsone

10

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Mark Woodhall

11

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Jithin George

12

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Mike Boggild

13

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Anu Jacob

15

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Kazuo Fujihara

16

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

9 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Pt 6

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1834-1849

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Neuromyelitis optica in Brazil: a study on clinical and prognostic factors

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

An epidemiological study of neuromyelitis optica in Cuba

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

High-risk syndrome for neuromyelitis optica: a descriptive and comparative study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

NMO-IgG in the diagnosis of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Clinical features of opticospinal multiple sclerosis with anti-aquaporin 4 antibody.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

NMO-IgG predicts the outcome of recurrent optic neuritis

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Natural history of the visual impairment of relapsing neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Optic neuromyelitis syndrome in Brazilian patients

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Characteristics of Devic's disease (neuromyelitis optica) in Mexico

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Age and disability accumulation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

The spectrum of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS109

21 January 2018

Identifiers

10.1093/BRAIN/AWS109

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38009295&oldid=2172924378"